Did you mean
virus vaccines

Search results - 9 results

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.

replication-defective viral vectors commonly used in gene therapy or vaccination. To our knowledge, this article presents the most extensive and up-to-date review of shedding data reported with OV employed in clinics. ...

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.

2 (2022) Keywords: Adult Antibodies, Viral Antigens, Viral Belgium Coronavirus Nucleocapsid Proteins COVID-19 COVID-19 Serological Testing Diagnostic Tests, Routine Enzyme-Linked Immunosorbent Assay Humans ...

Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2

Publication Type: Peer reviewed scientific article Authors: Aline Baldo; Amaya Leunda; Nicolas Willemarck; Katia Pauwels Source: Vaccines, Volume 9, Issue 5 (2021) Health Topics:  Health and ...

Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants

COVID-19 diagnosis is the detection of viral RNA by RT-qPCR with a specific set of primers and probe. It is important to frequently evaluate the performance of these tests and this can be done first by an in ...

Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.

Keersmaecker Source: Int J Mol Sci, Volume 21, Issue 15 (2020) Keywords: Betacoronavirus Coronavirus Infections Databases, Genetic Genome, Viral Humans Open Reading Frames Pandemics Pneumonia, Viral ...

Biosafety of viral vectors commonly used in gene therapy and vaccination.

Humans Organisms, Genetically Modified Risk Assessment Vaccination Health Topics:  Health and environment Category:  A1 FOS Classification:  3.03 Health sciences ...

Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.

Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Risk Assessment Vaccination vaccinia virus Viral Vaccines Abstract: The modified vaccinia virus Ankara (MVA) ...

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.

Clinical Trials as Topic Gene Transfer Techniques Genetic Therapy Genetic Vectors Humans Mammals Neoplasms Poxviridae Infections Practice Guidelines as Topic Vaccination vaccinia virus Viral Vaccines ...

GMO Regulatory Aspects of Novel Investigational Vaccine Candidates

state-of-play in Belgium, this chapter discusses examples of regulatory journeys of applications with genetically modified viral vectors and novel vaccine candidates that have been reviewed by GMO national ...

QR code

QR code for this page URL